Cipla celebrates 90 years with focus on quality products, global presence, and investment in research and technology.

Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...

Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, driven by higher sales of its respiratory and cancer drugs in its key ...

As a Lead Sponsor of this year's walk, Cipla USA continues to build on its legacy of over 10 years in the US generics pharmaceutical landscape, with a strong focus on respiratory care.

Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...

Cipla USA is a respiratory leader, ranking #2 in inhaler sales globally and in the top 3 for US generic respiratory sales (IQVIA TRx data as of February 2025).

NEW YORK, May 27, 2025 /PRNewswire/ -- Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG FORCE Walk, reaffirming its ...